Desensitization and resensitization of β1- and putative β4-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure

British Journal of Pharmacology

Volumn 128, Issue 7, 1999, Pages 1399-1406

  Kompa, Andrew R ^a   Summers, Roger J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cardiac failure; CGP12177A; Isoprenaline; Pertussis toxin; Putative 4 adrenoceptor; Rat atrium; RO 363; 1 adrenoceptor

Indexed keywords

1 (3,4 DIHYDROXYPHENOXY) 3 (3,4 DIMETHOXYPHENETHYLAMINO) 2 PROPANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALTHESIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRANOLOL; ISOPRENALINE; LIDOCAINE; PARTIAL AGONIST; PERTUSSIS TOXIN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; HEART FAILURE; HEART INFARCTION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TIME;

EID: 0032733036     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702920     Document Type: Article

References (30)

1. BENOVIC, J.L., SHORR, R.J., CARON, M.G. & LEFKOWITZ, R.J. (1984). The mammalian beta 2-adrenergic receptor: purification and characterization. Biochemistry, 23, 4510-4518.
2. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430-437.
3. BYLUND, D.B., BOND, R.A., CLARKE, D.E., EIKENBURG, D.C., ILLEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO, R.R., STROSBERG, A.D. & TRENDELENBURG, U.G. (1998). Adrenoceptors. In: Girdlestone, G. (ed). The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media:UK. pp. 58-74.
4. CARLSSON, E., ǍBLAD, B., BRÄNDSTRÖM, A. & CARLSSON, B. (1972). Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci., 11, 953-958.
5. CARON, M.G., KOBILKA, B.K., FRIELLE, T., BOLANOWSKI, M.A., BENOVIC, J.L. & LEFKOWITZ, R.J. (19881). Cloning of the cDNA and genes for the hamster and human beta 2-adrenergic receptors. J. Receptor Res. 8, 7-21.
6. CUBERO, A. & MALBON, C.C. (1984). The fat cell beta-adrenergic receptor. Purification and characterization of a mammalian beta 1-adrenergic receptor. J. Biol. Chem., 259, 1344-1350.
7. 3-adrenoceptor mRNA in rat tissues. Br. J. Pharmacol., 117, 210-216.
8. FRIELLE, T., COLLINS, S., DANIEL, K.W., CARON, M.G., LEFKOWITZ R.J. & KOBILKA, B.K. (1987). Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A., 84, 7920-7924.
9. FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blashko, H. & Muscholl, E. (eds.). Handbook of Experimental Pharmacologv. Springer-Verlag; New York. pp. 283-335.
10. 4-adrenoceptor. Br. J. Pharmacol., 122, 1244-1250.
11. GAUTHIER, C., TAVERNIER, G., CHARPENTIER, F., LANGIN, D. & LEMAREC, H. (1996). Functional beta(3)-adrenoceptor in the human heart. J. Clin. Invest., 98, 556-562.
12. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 60-70.
13. GU, X.H., KOMPA, A.R. & SUMMERS R.J. (1998). Regulation of β-adrenoceptors in a rat model of cardiac failure: effect of perindopril. J. Cardiovasc. Pharmacol., 32, 66-74.
14. 3-adrenoceptor modulation of contractile function in human ventricular myocytes. Circulation, 96 (Suppl): 1-53.
15. KAUMANN, A.J. (1989). Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci., 10, 316-320.
16. KAUFMANN, A.J. (1996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol., 117, 93-98.
17. KAUMANN, A.J. & LYNHAM, J.A. (1997). Stimulation of cyclic AMP-dependent protein kinase in rat atria by (-)-CGP 12177 through an atypical β-adrenoceptor. Br. J. Pharmacol., 120, 1187-1189.
18. 3-adrenoceptors and is coupled to a cyclic AMP-dependent pathway in rat and human myocardium. Br. J. Pharmacol., 120, 102P.
19. 3-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098.
20. KAUMANN, A.J. & MOLENAAR, P. (1997). Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn-Schmiedeberg's Arch. Pharmacol, 355, 667-681.
21. 3-adrenoceptor knockout mice. Mol. Pharmacol., 53, 670-675.
22. KOMPA, A.R., GU, X.H., EVANS, B.A. & SUMMERS R.J. (1999). Desensitization of cardiac β-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins. J. Mol. Cell Cardiol.,31, 1185-1201.
23. LEMOINE, H. & KAUMANN, A.J. (1983). A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a Schild-plot with apparent slope of unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in tracheae but not in right atria of guinea-pigs. Naunyn-Schmiedeberg's Arch. Pharmacol., 322, 111-120.
24. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 56-69.
25. MINNEMAN, K.P., HEDBERG, A. & MOLINOFF, P.B. (1979). Comparison of beta adrenergic receptor subtypes in mammalian tissues. J. Pharmacol. Exp. Ther., 211, 502-508.
26. 3-adrenoceptors. Br. J. Pharmacol., 120, 165-176.
27. 1-radrenergic receptors. J. Recep. Signal Trans. Res., 16, 1-23.
28. 1-adrenergic receptor gene: Developmental and cardiovascular effects. Proc. Natl. Acad. Sci. U.S.A., 93, 7375-7380.
29. 3H]-CGP 12177A as a radioligand for the 'putative β4-adrenoceptor' in rat atrium. Br. J. Pharmacol., 123, 371-380.
30. SUMMERS, R.J., STEPHENSON, J.A. & KUHAR, M.J. (1985). Localization of beta adrenoceptor subtypes in rat kidney by light microscopic autoradiography. J. Pharmacol. Exp. Ther., 232, 561-569.